This page shows the latest BI news and features for those working in and with pharma, biotech and healthcare.
Bristol Myers Squibb (BMS) and Zenas BioPharma have entered into a strategic license and collaboration agreement to develop and commercialise a novel, bi-functional antibody called obexelimab for autoimmune diseases. ... Obexelimab is an investigational
Talvey, which is administered as a weekly or bi-weekly subcutaneous injection after an initial step-up phase, is a bispecific antibody that binds to CD3 on the surface of T
Janssen, a Johnson &Johnson company, has announced that its bi-specific antibody, Talvey (talquetamab), has been recommended by the European Medicines Agency’s (EMA) human medicines committee for use in certain ... Despite recent advances, Janssen
The Swiss pharma added that the therapy also has the potential to improve adherence and compliance to treatment due to its possible bi-annual subcutaneous dosing regime.
Leqembi was granted traditional approval in the US earlier this month as a bi-weekly intravenous infusion. ... New results from an exposure/bioavailability and modelling study, presented at AAIC, show a SC dose of Leqembi administered once-weekly may
Boehringer Ingelheim (BI) has reported positive results from its phase 2b trial of spesolimab, demonstrating that the anti-interleukin-36 receptor antibody can prevent flares in adolescent and adult patients with ... BI reports that there is a ‘high
More from news
Approximately 4 fully matching, plus 111 partially matching documents found.
A true bi-directional conversation will reveal risks for non-adherence that can be addressed in prescriber-patient discussions.
Simultaneously targeting multiple tumour antigens using bi-specific chimeric antigen technology. Summary.
toxicity, including innovative bispecific monoclonal antibodies and Bi-specific T-cell engagers.
Since the initiative launched, AstraZeneca has seen two consecutive increases in the bi-annual employee engagement survey, with 69% of AstraZeneca employees agreeing that ‘Together, we are making progress in our
attractive and valuable bi-product.
More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.
We talk a lot about using emotions in healthcare communications, but not as much about the business intelligence(BI) behind it. ... What we don’t talk about as much is the business intelligence (BI) behind it.
patient voice and the critical role of BI in ensuring this is heard.
AbbVie. ALK. Astellas. AstraZeneca. Bayer. Boehringer Ingelheim. BI. BMS. Celgene. Sanofi Genzyme.
CSL are a healthcare specialist business intelligence consultancy. We help companies utilise tools like Power BI &Tableau.
market in areas such as Incentive Compensation, KAM, Coaching, Collaboration platforms and BI sol.
More from PMHub
Approximately 1 fully matching, plus 12 partially matching documents found.
No results were found
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....